Literature DB >> 10799849

Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.

A Bouchon1, J Dietrich, M Colonna.   

Abstract

We have identified new activating receptors of the Ig superfamily expressed on human myeloid cells, called TREM (triggering receptor expressed on myeloid cells). TREM-1 is selectively expressed on blood neutrophils and a subset of monocytes and is up-regulated by bacterial LPS. Engagement of TREM-1 triggers secretion of IL-8, monocyte chemotactic protein-1, and TNF-alpha and induces neutrophil degranulation. Intracellularly, TREM-1 induces Ca2+ mobilization and tyrosine phosphorylation of extracellular signal-related kinase 1 (ERK1), ERK2 and phospholipase C-gamma. To mediate activation, TREM-1 associates with the transmembrane adapter molecule DAP12. Thus, TREM-1 mediates activation of neutrophil and monocytes, and may have a predominant role in inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799849     DOI: 10.4049/jimmunol.164.10.4991

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  396 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

Review 2.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

3.  Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.

Authors:  Nasim A Begum; Kazuo Ishii; Mitsue Kurita-Taniguchi; Masako Tanabe; Mika Kobayashi; Yasuhiro Moriwaki; Misako Matsumoto; Yasuo Fukumori; Ichiro Azuma; Kumao Toyoshima; Tsukasa Seya
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

4.  Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.

Authors:  Gimano D Amatngalim; Anastasia Nijnik; Pieter S Hiemstra; Robert E W Hancock
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 5.  New therapeutic strategies targeting transmembrane signal transduction in the immune system.

Authors:  Alexander B Sigalov
Journal:  Cell Adh Migr       Date:  2010-04-24       Impact factor: 3.405

Review 6.  Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Guido R Y De Meyer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

7.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells.

Authors:  D N Quan; M D Cooper; J L Potter; M H Roberts; H Cheng; G A Jarvis
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

9.  Stimulation of the molecule 4-1BB enhances host defense against Listeria monocytogenes infection in mice by inducing rapid infiltration and activation of neutrophils and monocytes.

Authors:  Sang-Chul Lee; Seong-A Ju; Boo-Hee Sung; Sook-Kyoung Heo; Hong Rae Cho; Eun A Lee; Jung Dae Kim; In Hee Lee; Sang-Min Park; Quang Tam Nguyen; Jae-Hee Suh; Byung-Sam Kim
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

10.  DAP12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation.

Authors:  Jessica H Spahn; Wenjun Li; Alejandro C Bribriesco; Jie Liu; Hua Shen; Aida Ibricevic; Jie-Hong Pan; Bernd H Zinselmeyer; Steven L Brody; Daniel R Goldstein; Alexander S Krupnick; Andrew E Gelman; Mark J Miller; Daniel Kreisel
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.